1. Home
  2. ALKS vs PLXS Comparison

ALKS vs PLXS Comparison

Compare ALKS & PLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$47.41

Market Cap

8.7B

Sector

Health Care

ML Signal

HOLD

Logo Plexus Corp.

PLXS

Plexus Corp.

HOLD

Current Price

$240.87

Market Cap

7.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALKS
PLXS
Founded
1987
1979
Country
Ireland
United States
Employees
N/A
20000
Industry
Biotechnology: Pharmaceutical Preparations
Electrical Products
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
8.7B
7.2B
IPO Year
2012
1995

Fundamental Metrics

Financial Performance
Metric
ALKS
PLXS
Price
$47.41
$240.87
Analyst Decision
Buy
Strong Buy
Analyst Count
14
4
Target Price
$43.43
$206.50
AVG Volume (30 Days)
1.4M
255.9K
Earning Date
05-05-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
56.11
EPS
N/A
4.90
Revenue
$1,475,899,000.00
N/A
Revenue This Year
$24.26
$14.31
Revenue Next Year
$4.47
$8.29
P/E Ratio
N/A
$50.09
Revenue Growth
N/A
N/A
52 Week Low
$25.17
$132.03
52 Week High
$55.67
$307.06

Technical Indicators

Market Signals
Indicator
ALKS
PLXS
Relative Strength Index (RSI) 40.85 40.91
Support Level $47.66 $233.67
Resistance Level $51.25 $297.13
Average True Range (ATR) 1.41 8.44
MACD -0.12 -1.50
Stochastic Oscillator 9.75 20.57

Price Performance

Historical Comparison
ALKS
PLXS

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

About PLXS Plexus Corp.

Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.

Share on Social Networks: